Daniel G. Kramer

Nuclear Medicine
11 South Rd
Farmington,, CT 06032

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors.

A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors.

Journal: BMC cancer
Published: June 14, 2012
Showing 1-1 of 1

Last Updated: 09/26/2026